Jagsonpal Pharmaceuticals Limited 507789 Financial and Strategic SWOT Analysis Review

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Physician Views: New data for Novartis% LCZ696 set the Street abuzz, but how do cardiologists see it fitting into highly genericised heart failure market?

Physician Views: New data for Novartis% LCZ696 set the Street abuzz, but how do cardiologists see it fitting into highly genericised heart failure market?

  • $ 645
  • Industry report
  • by Firstword Pharma
  • Jan 2015

The potential blockbuster status of Novartis' LCZ696 has seemingly been cemented in the eyes of the Street thanks to solid results from the Phase III PARADIGM-HF study that were presented over the weekend. Indeed, the chronic heart failure agent is believed to represent both a significant growth drive ...

Industries: Pathology | Countries: United States

Kenya Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Kenya Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • January 2015
  • 104 pages

BMI View: The Kenyan pharmaceuticals and healthcare industry presents significant revenue-earning opportunities for drug firms . Growth in the segment will be boosted by strong demographics, increased healthcare needs, longer life expectancy, rising healthcare spending in the public and private segments ...

Industries: Pharmaceutical | Countries: Kenya

South Korea Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

South Korea Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • January 2015
  • 142 pages

BMI View: Unlike some observers, BMI classes South Korea as a developed country and this is underpinned by the balanced risk/reward profile of its pharmaceutical industry . Negative attributes include the sub-standard enforcement of intellectual property rights, industry access issues and price cuts. ...

Industries: Pharmaceutical | Countries: South Korea

Thailand Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Thailand Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • January 2015
  • 116 pages

BMI View: Thailand is a moderately attractive pharmaceutical industry for multinationals. On the positive side, rewards are potentially considerable, given the country’s epidemiological profile and the growing population numbers. However, the government’s stance on compulsory licences and regulatory ...

Industries: Drug and Medication | Countries: Thailand

Samjin Pharmaceutical Company Limited

Samjin Pharmaceutical Company Limited

  • $ 55
  • Company report
  • by Wright Investors' Service
  • January 2015
  • 57 pages

A textual analysis of the financial results for Samjin Pharmaceutical Company Limited compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. ...

Industries: Pharmaceutical

Yungjin Pharmaceutical Company Limited

Yungjin Pharmaceutical Company Limited

  • $ 55
  • Company report
  • by Wright Investors' Service
  • January 2015
  • 57 pages

A textual analysis of the financial results for Yungjin Pharmaceutical Company Limited compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. ...

Industries: Pharmaceutical

Samsung Pharmaceutical Co Ltd

Samsung Pharmaceutical Co Ltd

  • $ 55
  • Company report
  • by Wright Investors' Service
  • January 2015
  • 57 pages

A textual analysis of the financial results for Samsung Pharmaceutical Co Ltd compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business ...

Industries: Pharmaceutical

Choa Pharmaceutical Company Limited

Choa Pharmaceutical Company Limited

  • $ 55
  • Company report
  • by Wright Investors' Service
  • January 2015
  • 56 pages

A textual analysis of the financial results for Choa Pharmaceutical Company Limited compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. ...

Industries: Pharmaceutical

Korea United Pharmaceutical Incorporated

Korea United Pharmaceutical Incorporated

  • $ 55
  • Company report
  • by Wright Investors' Service
  • January 2015
  • 57 pages

A textual analysis of the financial results for Korea United Pharmaceutical Incorporated compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. ...

Industries: Pharmaceutical | Countries: South Korea

Myungmoon Pharmaceutical Company Limited

Myungmoon Pharmaceutical Company Limited

  • $ 55
  • Company report
  • by Wright Investors' Service
  • January 2015
  • 57 pages

A textual analysis of the financial results for Myungmoon Pharmaceutical Company Limited compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. ...

Industries: Pharmaceutical

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 618 4302

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.